NCT03130036View on ClinicalTrials.gov

Biodistribution of [11C]Acetoacetate/[18F]Fluorodeoxyglucose in Subjects With Risk Factors for Alzheimer's Disease

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

June 9, 2015

Primary Completion Date

June 19, 2024

Study Completion Date

June 19, 2024

Conditions
Mild Cognitive Impairment
Interventions
OTHER

[11C]Acetoacetate[18F]Fluorodeoxyglucose positron emission tomography scan

A PET scan to measure uptake of acetoacetate and glucose in the brain will be administered to all participants enrolled in the study

Trial Locations (1)

27157

Wake Forest School of Medicine, Winston-Salem

All Listed Sponsors
lead

Wake Forest University Health Sciences

OTHER

NCT03130036 - Biodistribution of [11C]Acetoacetate/[18F]Fluorodeoxyglucose in Subjects With Risk Factors for Alzheimer's Disease | Biotech Hunter | Biotech Hunter